{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Standard-of-Care&page=28", "query": { "intervention": "Standard-of-Care", "page": 28 }, "page_size": 10 }, "pagination": { "page": 28, "page_size": 10, "total_count": 14437, "total_pages": 1444, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Standard-of-Care&page=29&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Standard-of-Care&page=27&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-15T05:28:45.446Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT02925442", "title": "Genicular Radiofrequency Ablation for Unilateral Knee Arthroplasty Pain Management", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Osteoarthritis of the Knee" ], "interventions": [ { "name": "t-RFA", "type": "PROCEDURE" }, { "name": "C-RFA", "type": "PROCEDURE" }, { "name": "Control", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE" ], "sponsor": "Lyman Medical Research Foundation, Inc.", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 150, "start_date": "2017-01-25", "completion_date": "2020-02-07", "has_results": false, "last_update_posted_date": "2019-05-24", "last_synced_at": "2026-10-15T05:28:45.446Z", "location_count": 2, "location_summary": "Coeur d'Alene, Idaho • Spokane, Washington", "locations": [ { "city": "Coeur d'Alene", "state": "Idaho" }, { "city": "Spokane", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT02925442" }, { "nct_id": "NCT04880642", "title": "A Trial to Investigate Recovery From COVID-19 With C21 in Adult Subjects", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "COVID-19" ], "interventions": [ { "name": "C21", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Vicore Pharma AB", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 272, "start_date": "2021-09-16", "completion_date": "2022-04-25", "has_results": true, "last_update_posted_date": "2023-12-14", "last_synced_at": "2026-10-15T05:28:45.446Z", "location_count": 6, "location_summary": "Orange, California • Winfield, Illinois • Fort Wayne, Indiana + 3 more", "locations": [ { "city": "Orange", "state": "California" }, { "city": "Winfield", "state": "Illinois" }, { "city": "Fort Wayne", "state": "Indiana" }, { "city": "Minot", "state": "North Dakota" }, { "city": "Allentown", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT04880642" }, { "nct_id": "NCT07749586", "title": "A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Advanced Solid Tumor" ], "interventions": [ { "name": "ARV-6723", "type": "DRUG" }, { "name": "Pembrolizumab", "type": "DRUG" }, { "name": "SOC", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Arvinas Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 499, "start_date": "2026-07-29", "completion_date": "2032-03-31", "has_results": false, "last_update_posted_date": "2026-10-13", "last_synced_at": "2026-10-15T05:28:45.446Z", "location_count": 4, "location_summary": "New York, New York • Huntersville, North Carolina • San Antonio, Texas + 1 more", "locations": [ { "city": "New York", "state": "New York" }, { "city": "Huntersville", "state": "North Carolina" }, { "city": "San Antonio", "state": "Texas" }, { "city": "Fairfax", "state": "Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT07749586" }, { "nct_id": "NCT04093869", "title": "Improving Lung Transplant Outcomes With Coping Skills and Physical Activity", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Post-Lung Transplantation" ], "interventions": [ { "name": "Coping Skills Training combined with Exercise (CSTEX)", "type": "BEHAVIORAL" }, { "name": "Standard of Care plus Education (SOC-ED)", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Duke University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 180, "start_date": "2019-11-06", "completion_date": "2026-02-01", "has_results": true, "last_update_posted_date": "2026-02-27", "last_synced_at": "2026-10-15T05:28:45.446Z", "location_count": 1, "location_summary": "Durham, North Carolina", "locations": [ { "city": "Durham", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT04093869" }, { "nct_id": "NCT00310141", "title": "Computer-Assisted Counseling in Helping African American Smokers Stop Smoking", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Lung Cancer" ], "interventions": [ { "name": "Smoking cessation intervention", "type": "BEHAVIORAL" }, { "name": "Counseling intervention", "type": "OTHER" }, { "name": "Nicotine patch", "type": "DRUG" } ], "intervention_types": [ "BEHAVIORAL", "OTHER", "DRUG" ], "sponsor": "M.D. Anderson Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "21 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "21 Years to 65 Years" }, "enrollment_count": 462, "start_date": "2002-04-08", "completion_date": "2016-08-30", "has_results": false, "last_update_posted_date": "2017-08-22", "last_synced_at": "2026-10-15T05:28:45.446Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00310141" }, { "nct_id": "NCT05535166", "title": "Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Medulloblastoma" ], "interventions": [ { "name": "Surgical resection", "type": "PROCEDURE" }, { "name": "Ommaya/VPS", "type": "PROCEDURE" }, { "name": "Methotrexate", "type": "DRUG" }, { "name": "Cisplatin", "type": "DRUG" }, { "name": "Vincristine", "type": "DRUG" }, { "name": "Cyclophosphamide", "type": "DRUG" }, { "name": "Carboplatin", "type": "DRUG" }, { "name": "Topotecan", "type": "DRUG" }, { "name": "Etoposide", "type": "DRUG" }, { "name": "Pegfilgrastim", "type": "DRUG" }, { "name": "Filgrastim", "type": "DRUG" }, { "name": "Irradiation", "type": "RADIATION" }, { "name": "Educational and Media Intervention", "type": "OTHER" }, { "name": "SOC, Educational and Media Intervention", "type": "OTHER" } ], "intervention_types": [ "PROCEDURE", "DRUG", "RADIATION", "OTHER" ], "sponsor": "St. Jude Children's Research Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": "59 Months", "sex": "ALL", "summary": "Up to 59 Months" }, "enrollment_count": 130, "start_date": "2022-12-20", "completion_date": "2035-07", "has_results": false, "last_update_posted_date": "2026-09-15", "last_synced_at": "2026-10-15T05:28:45.446Z", "location_count": 10, "location_summary": "Palo Alto, California • Orlando, Florida • Tampa, Florida + 7 more", "locations": [ { "city": "Palo Alto", "state": "California" }, { "city": "Orlando", "state": "Florida" }, { "city": "Tampa", "state": "Florida" }, { "city": "Ann Arbor", "state": "Michigan" }, { "city": "Minneapolis", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT05535166" }, { "nct_id": "NCT04903288", "title": "A Study of SmartFlow Magnetic Resonance (MR) Compatible Ventricular Cannula for Administering Eladocagene Exuparvovec to Pediatric Participants", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "AADC Deficiency" ], "interventions": [ { "name": "Eladocagene Exuparvovec", "type": "GENETIC" } ], "intervention_types": [ "GENETIC" ], "sponsor": "PTC Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "1 Year", "maximum_age": "17 Years", "sex": "ALL", "summary": "1 Year to 17 Years" }, "enrollment_count": 13, "start_date": "2021-05-12", "completion_date": "2028-04-30", "has_results": true, "last_update_posted_date": "2026-04-24", "last_synced_at": "2026-10-15T05:28:45.446Z", "location_count": 4, "location_summary": "Boston, Massachusetts • Durham, North Carolina • Cincinnati, Ohio + 1 more", "locations": [ { "city": "Boston", "state": "Massachusetts" }, { "city": "Durham", "state": "North Carolina" }, { "city": "Cincinnati", "state": "Ohio" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT04903288" }, { "nct_id": "NCT07103486", "title": "A Study to Evaluate the Therapeutic Benefit of Tisagenlecleucel Compared to Existing Standard of Care in German Adult Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Diffuse Large B-Cell Lymphoma" ], "interventions": [], "intervention_types": [], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 264, "start_date": "2021-04-01", "completion_date": "2023-01-31", "has_results": false, "last_update_posted_date": "2025-08-05", "last_synced_at": "2026-10-15T05:28:45.446Z", "location_count": 1, "location_summary": "East Hanover, New Jersey", "locations": [ { "city": "East Hanover", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT07103486" }, { "nct_id": "NCT05265169", "title": "Ablation With Confirmation of Colorectal Liver Metastases (ACCLAIM)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Colorectal Liver Metastases" ], "interventions": [ { "name": "Microwave ablation", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Society of Interventional Oncology", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 275, "start_date": "2023-01-13", "completion_date": "2027-12-10", "has_results": false, "last_update_posted_date": "2024-01-17", "last_synced_at": "2026-10-15T05:28:45.446Z", "location_count": 5, "location_summary": "Miami, Florida • Rochester, Minnesota • New York, New York + 2 more", "locations": [ { "city": "Miami", "state": "Florida" }, { "city": "Rochester", "state": "Minnesota" }, { "city": "New York", "state": "New York" }, { "city": "Houston", "state": "Texas" }, { "city": "Milwaukee", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT05265169" }, { "nct_id": "NCT05934669", "title": "IN Midazolam vs IN Dexmedetomidine vs IN Ketamine During Minimal Procedures in Pediatric ED", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Laceration of Skin", "Anxiety", "Discharge Time" ], "interventions": [ { "name": "Intranasal Midazolam", "type": "DRUG" }, { "name": "Intranasal Dexmedetomidine", "type": "DRUG" }, { "name": "Intranasal Ketamine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Oklahoma", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "1 Year", "maximum_age": "5 Years", "sex": "ALL", "summary": "1 Year to 5 Years" }, "enrollment_count": 90, "start_date": "2023-11-14", "completion_date": "2025-06", "has_results": false, "last_update_posted_date": "2024-06-28", "last_synced_at": "2026-10-15T05:28:45.446Z", "location_count": 1, "location_summary": "Oklahoma City, Oklahoma", "locations": [ { "city": "Oklahoma City", "state": "Oklahoma" } ], "official_url": "https://clinicaltrials.gov/study/NCT05934669" } ] }